chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented to the vaccination site on 12/21/21. Patient received first dose on 4/15/21 and second dose 5/13/21. Patient received booster Moderna dose (LOT#: 070H21A) on 12/21/21 at 1638. The client notified 2 EMTs that she felt her heart racing for about 10 minutes. RN arrived on scene and assessed patient. EMT took patients vital signs. BP: 140/84, HR: 70, RR: 16. Patient stated that she felt pressure in her chest. RN called 911 at 1604. EMS arrived on scene at 1615 and took over. EMS assessed patient. Patient signed AMA form. EMS left vaccination site at 1622. RN educated patient on adverse effects of COVID vaccine and when to seek EMS. RN recommended that patient go see PCP about her symptoms after booster dose. Patient verbalized understanding. Patient left vaccination site at 1630 unassisted  with a steady gait with her son and husband.
Approximately 6 hours after injection, fainted 4-5 times. Struggled with consciousness for about 10 minutes. Had low blood pressure and required emergency medical attention.
Pt got Tdap & 3 days later got redness & pain & swelling & F/C at injection site & redness spreading, tx'd with BACTRIM 7/13/11.
Information has been received from a Registered Nurse concerning a female patient who on an unspecified date was vaccinated with a third dose of GARDASIL (lot # not reported). After third dose of vaccine a patient's laboratory work test came back positive for Human Papilloma Virus (HPV). The patient sought medical attention office visit and spoke to the nurse. The patient's outcome was unknown. No further information is available.
Cold/ Stuffy nose; Cough; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold/ Stuffy nose) and COUGH (Cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold/ Stuffy nose) and COUGH (Cough). At the time of the report, NASOPHARYNGITIS (Cold/ Stuffy nose) and COUGH (Cough) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Reporter did not allow further contact
Experienced sharp and local chest pain on the left side of my chest, three days after getting the first Pfizer shot on June 6.  Was later diagnosed with pericarditis by my primary doctor, Dr, and Cardiologist Dr.  Was initially prescribed Advil 3 times a day for a week, with no change in pain or discomfort.  I was then prescribed  indomethacin 3x a day, and colchicine 2x a day. Took those two medications for about two months, and later suffered from esophagitis the following month from the long-term use of NSAIDs. Took 3-4 months to fully recover from all pain and inflammation.
5hr p/vax pt devel hives head to the afeb;wheezing morning of 5JUN98;still has hives;
Mild headache that evening, arm slightly sore during the night and the next day.  Frontal headache and muscle aches the next day on 1/22/21.  Some fatigue and nasal congestion that next day as well.  Some fatigue and headache on 1/23/21.  Took Tylenol once on 1/22 and 1/23.
Following administration of H1N1 vaccine to L arm pt developed SOB, flushing, weird sensation in chest, difficulty swallowing. Seen immediately in ER, given epinephrine 0.4 SQ, BENADRYL 50 mg IVP, SOLU-MEDROL 250 mg IVP, ZANTAC 50 mg IVP, 1000 cc NS. Vitals 154/90, 107, 24, 98.3.
This is a spontaneous report received from a contactable physician (patient). A 39-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# EK5730), at the age of 39, intramuscularly, in left deltoid, on Dec 19, 2020, at 08:00, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. The patient had a migraine, onset Dec 19, 2020 20:00, with outcome of recovered. No therapeutic measures taken as a result of migraine. The reporter believed the product had a causal effect to the adverse event. No follow-up attempts possible. No further information expected.
I had numbness on left side of my cheek; This is a spontaneous report from a contactable Nurse. A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On an unspecified date caller reports that she "received the COVID shot at 5pm and within an hour after leaving "she had numbness on left side of her cheek". She reports that her left cheek feels like it would if Novocain was injected into it. She reports having taken Tylenol in the morning and plans to see her doctor but was advised to call and report this symptom. Outcome of events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVId Vaccine Breakthrough Case  Pfizer Dose 1 5/4/21 (ER8736) Pfizer Dose 2 5/26/21 (EW0168) COVID Positive 12/7/21  12/7/21: Patient 64-year-old female with history of CKD stage 4, diabetes mellitus, obesity, hyperlipidemia, hypertension, no history of asthma or COPD however uses inhaler as needed she does not know why, no history of obstructive sleep apnea, received COVID-19 vaccine in April, presenting to the emergency department with a complaint of worsening shortness of breath of couple of days duration.  Associated with cough and sputum production, denies any fever or chills, reports worsening shortness of breath, reports close contact with COVID-19 positive friend, she also reports lower extremity edema for which she takes torsemide however denies heart failure.   In ED, upon arrival O2 saturation 89% on room air, was placed on 2 L and escalated to 5 L upon my exam.  Chest x-ray suggestive bilateral pneumonia, was given Rocephin and Zithromax.  Creatinine 2.3 and seems to be at baseline, troponin 0.04 with no chest pain, blood gas showed CO2 retention, ED provider requesting admission.  12/30/21: care coordination intervention for oxygen/ home medical equipment ordered and delivery  Continue steroid taper as ordered,  continue other home medications  Stable for discharge home today with home  health services and program.
dose 1 2/1/21 dose 2 2/26/21 booster 10/11/21  fully vax employee positive 12/27/21 onset of symptoms 12/22/21
66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
I had covid after receiving my 5th dose. I experienced a sore throat. that went away by the next day.  my biggest side effect was exhaustion/fatigue. That lasted about a full week.  by Sunday 4/9/2023 when I tested positive I had a cough, headache. I still have the cough now.  I didn't have a fever or vomiting/ diarrhea.
flushing; chest pressure; lightheadedness; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female (not pregnant) patient received BNT162B2 (lot number EH 9899) first dose intramuscularly on right arm on 30Dec2020 09:30 AM at single dose for COVID-19 immunization. Medical history included HTN/GERD, allergies to pineapple and sulfa. Concomitant medications in two weeks included diltiazem (CARDIZEM), valsartan (DIOVAN), omeprazole (PROTONIX), meloxicam (MOBIC), docusate and bupropion hydrochloride (WELLBUTRIN). No other vaccine in four weeks. Patient experienced flushing, chest pressure and lightheadedness on 30Dec2020 09:30 AM, resulted in: Emergency room/department or urgent care and received treatment as ER evaluation. No COVID prior vaccination. No COVID tested post vaccination. The outcome of the events was recovered in Dec2020. The seriousness was reported as no.
Information has been received from a lawyer regarding a case in litigation concerning a patient (age and gender unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2014, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 10-SEP-2016, the patient was treated at a medical facility for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Patient had not received any vaccines from primary series, was administered the Moderna Bivalent Booster. No adverse events reported. Per CDC recommendations, patient to complete dose 1 of primary series immediately.
Injection hurts; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 08-JUL-2023, the patient received the 1st dose of Shingles vaccine. On 08-JUL-2023, less than a day after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: Injection hurts). The outcome of the injection site pain was not reported.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.     It was unknown if the company considered the injection site pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 11-JUL-2023 This case was reported by a patient via interactive digital media. Any pharmacy could administer the shingles vaccine.  The patient's doctor recommended it to him/her.  The patient did not want to get it because some people said that they had a bad reaction to it, he told him/her it was preferable to have a reaction for a few days over the pain of having shingles for months, he/she followed his advice, he/she decided to get it at the time of reporting and the injection only hurt a bit.  The reporter stated that he/she think you were eligible after 50.  The patient took his advice and he/she would get the second one later.
patient reported feeling hot in the observation area and was brought to the EMS room H2O given allowed to rest discharged in no distress @ 935.
Pt devel fever 103, admitted to hosp due to other chronic condition-bronchopulmonary dysplasia & rt lobe atelectasis to r/o sepsis;
Patient's arm is red, hot, swollen, and she has a headache. Rash is about 3 inches with a darker red center.
Patient presented to the ED on 5/4/21 and was subsequently hospitalized within 6 weeks of receiving COVID vaccination.
Headache; Coughing; This is a spontaneous case, reported by other non-healthcare professional to agency [reference number: SEQ19-06089] and initially received on 04-Nov-2019, concerning a 7-year-old, female patient.  The patient's medical history was not reported. The patient's concomitant medications were not provided.  On 30-Sep-2019, the patient was administered Afluria Quadrivalent [influenza vaccine; dose, route of administration, anatomical location, batch number and expiry date: not reported] for prevention of seasonal influenza.  On the same day, after vaccination, the patient experienced headache and coughing. No corrective treatment was given for the events.  At the time of initial reporting, the outcome of the events was not reported.  This case was assessed as non-serious.   The reporter did not provide the causality assessment.  This case is linked to cases: 201905875, 201905876 and 201905877 (same reporter).  Company Comment: The events of 'headache' and 'coughing' are considered related to Afluria Quadrivalent.; Sender's Comments: The events of 'headache' and 'coughing' are considered related to Afluria Quadrivalent.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, or concomitant medications were not reported. On 08-FEB-2019, the patient was vaccinated with an expired dose of GARDASIL 9, lot # M030380, expiry date: 01-FEB-2019, for prophylaxis (dose # and route were not reported). No adverse effects were reported.
I experienced symptoms of fatigue to the point of spending 3 days on the couch, and my energy levels have not recovered. Beginning on 09/20/22 I developed a persistent cough that does become mucous producing periodically. On 10/31/22 I began having to use my rescue inhaler very often due to frequent asthma attacks. I was prescribed a Zpack on 11/02/22 and began to feel improved 11/07/22. My symptoms returned 11/12/22, I began having severe asthma attacks 11/24/22 and 11/25/22 resulting in multiple urgent care visits. I began a second Zpack, benzonatate, and prednisone on 12/02/22. I was diagnosed with Bronchitis Pneumonia 12/02/22. My symptoms have begun to improve slightly, but I do not feel recovered.
Pt vaccinated with Heptavax-B experienced visual & other symptoms such as headaches, seen by Ophthalmologist. Dx as having Vogt-Koyanagi-Harada's synd treated w/steroid eye drops. Approx 1wk later rt eye was diminished to only count fingers
Weak, nausea, hives, high fever 102.9 for 16 hours, chills, joint pain (arms, hips, legs and back), symptoms improved after 32 hours. Loss of voice at 42 hours but has since came back.
Swelling at injection site immediately after injection. Slight light-headedness  Vital Signs: BP 180/96 HR 86 O2sat 98%  Skin Signs: Warm and dry, Clammy, other: swelling at injection site  Circulation: Cap refill <2sec  Respiratory: Breath and sound clear bilaterally  Initial Treatment: Observed swelling marked out original size checked for enlargement or skrinking.  1:48 PM: BP 160/96 HR 86 O2sat 98%  Skin Signs: Cool and dry, clammy, diaphoretic, other: plush  2:08 PM: BP 156/104 HR 93 O2sat 96%  Skin Signs: Warm and dry (neck/head), cool and dry (arms)  2:30 PM:  BP 142/100 HR 90 O2sat 96%  Up and walking, no dizziness of pink warm dry, alert x3 continues to have decreasing swelling in left deltoid, tender to touch, decreasing redness at site, attempted to call wife x2 and friend x1 Disposition:  Other: Pt will wait for friend who will follow pt in his car to where he will meet up w/ wife. Pt advised to notify PCP of rxn to vaccine and to notify future vaccinators of this fact.
Arm is sore at site still but no swelling or redness the patient has complained of persistent, localized pain with no abscess, hematoma, or neuropathy, no structural injury or allergic reaction.
Initial information received on 08-Oct-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 37 years old female patient who received vaccine FLUZONE QUADRIVALENT. The patients past medical history, concomitant medication and family history were not provided. On 08-Oct-2018, the patient received a 0.5ml dose of suspect FLUZONE QUADRIVALENT lot UT5934LA, expiry date 30-Jun-2018 via intramuscular route in unknown administration site. It was an actual medication error due to expired vaccine used. It was reported that patient given FLUZONE on 08-Oct-2018 from last year that expired on 30-Jun-2018. It was unknown whether patient experienced any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Vaccine leaked out because the needle got disconnected from syringe; Dose ran down patient's arm; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Vaccine leaked out because the needle got disconnected from syringe) and UNDERDOSE (Dose ran down patient's arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Vaccine leaked out because the needle got disconnected from syringe) and UNDERDOSE (Dose ran down patient's arm). At the time of the report, INCORRECT DOSE ADMINISTERED (Vaccine leaked out because the needle got disconnected from syringe) and UNDERDOSE (Dose ran down patient's arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter. No concomitant medications were provided by reporter.
pruritis; erythema; This spontaneous case was reported by a non-health professional and describes the occurrence of PRURITUS (pruritis) and ERYTHEMA (erythema) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Adhesive plaster sensitivity and Hypersensitivity.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PRURITUS (pruritis) and ERYTHEMA (erythema). The patient was treated with ACETAMINOPHEN for Fever, at an unspecified dose and frequency. On 11-Apr-2021, PRURITUS (pruritis) had resolved. At the time of the report, ERYTHEMA (erythema) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.9 degree Celsius High.         This case was linked to MOD-2021-053254 (Patient Link).
Patient experienced vertigo and nausea about 5 to 10 minutes after being  vaccinated. She was given water and observed for another 30 minutes, after which she was feeling better.
I had adverse reactions to both the first and second vaccines, and the third does/booster shot was no different, but my side effects were worse. Day of, my arm was sore and red. The day after I felt horrible, headache, body aches, and my entire left auxiliary lymph node was incredibly swollen. I could barely put my arm down and couldn't not sleep on or lean on my entire left side. This stayed swollen for about 2 weeks and had some bruising coloration.   This has also continued to mess up my menstrual cycle as the first one had started in July of 2021. My periods are lasting 16-19 days long and very painful. lots of cramping and headaches/backaches. (on top of those two I get regularly) I have been having cramping issues even when I am not on my cycle. Tylenol and Ibuprofen have not been effective for any of these. I have been having menstrual cycle issues since July and August of 2021 after the first vaccine and it has only continued. I reported that on here but I'm not sure if it was processed. The lot number on my card is not legible so that was kicked back to me, and then it never allowed me to try an update it.
Experiencing swollen, very tender lymph nodes under armpit.  Taking Tylenol for pain. Symptoms are getting better.
pt recv vax 8JAN99 & immed became irritable, described as unhappy, cranky, & crying;pt was sleeping a lot & bears down when nursing;pt reportedly has nl bowel movements;the unhappiness, somnolence, & crying resolved w/in 3 days;
Was OK until later on in the evening when I began to get severely dizzy and cold not walk. Throwing up constantly-that lasted for 3-4 hours when I called 911 to take me to local General hospital, and began anti nausea meds. The ER doc was concerned because they saw something unusual on my EKG- a slightly long segment which was 515. They recommend that I get another EKG next week. I'm checking permanent disability at this point below until I get a second EKG and see what's happening there.
pt recv vax & 9 days later came down w/chickenpox;it was not a mild case;pt was covered w/lesions & exp high temps;itching was minimal;
This spontaneous report was received from a Nurse Practitioner refers to a 27 year old female patient. Patient's medical history and drug reactions included Penicillin (anaphylaxis 20 years ago). On an unspecified date in 2009 and 2012 the patient was vaccinated with (Oka/Merck) VARIVAX subcutaneous. No concomitant therapies were reported. On 17-JUL-2014, the patient had blood titer drawn for VZV (Varicella-Zoster virus) antibody level and the results was 0.9gp ELISA units/ml. No treatment was given for the adverse event. The outcome of blood titer drawn for VZV antibody level. The results was 0.9 gp ELISA units/ml was unknown. Additional information has been requested.
Rash and hives on back and lip swelling every night beginning the first night after vaccine administration and continuing for a few weeks.  Medrol dosepack #21 and Benadryl.